Last reviewed · How we verify

NCT05426564

Exploratory Assessment of the Quantra® System in Adult ECMO Patients

Completed Last updated 15 June 2023
What this trial tests

trial testing Quantra System in Blood Loss in 10 participants. Completed in 1 June 2023.

Timeline
27 September 2022
Primary endpoint
17 May 2023
1 June 2023

Quick facts

Lead sponsorHemoSonics LLC
StatusCompleted
Study typeOBSERVATIONAL
Enrollment10
Start date27 September 2022
Primary completion17 May 2023
Estimated completion1 June 2023
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

HemoSonics LLC — full company profile →

Who can join

18 and older, any sex, with Blood Loss or Thrombosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a prospective, observational exploratory study of the performance of the Quantra System in adult patients that are undergoing an arterio-venous (AV), veno-venous (VV) ECMO or extra-corporeal life support (ECLS) procedure.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Quantra System

Trials testing the same drug.

Other recruiting trials for Blood Loss

Currently open trials in the same condition.

Other HemoSonics LLC trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05426564.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing